The anti IL-17A IgG1 antibody distributes in dermal interstitial fluid as demonstrated by using dermal open flow microperfusion after a single 300 mg subcutaneous administration; assessment in healthy volunteers and patients with moderate-to-severe plaque

Publikation aus Health

Bruin G., Dragatin C. , Aigner B., Polus F., Calonder C., Froeliger C., Tiffner K., Bodenlenz M., Mader J., Korsatko S. , Ratzer M., Pieber T., Loesche C., Sinner F.

Journal of Investigative Dermatology 134:S18-S18, 2014